Claris Lifesciences Ltd (CLAI.BO) Quote| Reuters.com
Edition:
United States

Claris Lifesciences Ltd (CLAI.BO)

CLAI.BO on Bombay Stock Exchange

206.00INR
24 Jun 2016
Change (% chg)

Rs-9.60 (-4.45%)
Prev Close
Rs215.60
Open
Rs204.80
Day's High
Rs212.00
Day's Low
Rs188.00
Volume
103,474
Avg. Vol
94,382
52-wk High
Rs266.00
52-wk Low
Rs126.10

CLAI.BO

Chart for CLAI.BO

About

Claris Lifesciences Limited is an India-based holding company. The Company is engaged in manufacturing of drugs and pharmaceuticals products. The Company through its subsidiaries manufactures and markets products, including anesthesia, blood products, anti-infective and plasma volume expanders and offers intravenous nutrition... (more)

Overall

Beta: 1.12
Market Cap(Mil.): Rs11,240.96
Shares Outstanding(Mil.): 54.57
Dividend: 2.00
Yield (%): --

Financials

  CLAI.BO Industry Sector
P/E (TTM): -- 32.69 34.11
EPS (TTM): -3.70 -- --
ROI: 4.41 15.00 14.23
ROE: -1.57 16.08 15.46

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : GlobalData
$300.00
Provider : Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.